Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Clinical trial NCT00117936 · UNKNOWN
Trial details
- NCT number
- NCT00117936
- Sponsor
- Venturis Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2022-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.